)
)
Laurus Labs Investor Relations Material
Latest events
Q2 24/25
Laurus Labs
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Laurus Labs Ltd
Access all reports
Laurus Labs Limited, a pharmaceutical company, develops, manufactures, and sells active pharmaceutical ingredients (APIs) and formulations in India. It involves in the development of antiviral APIs; generic APIs for hepatitis C and HIV Darunavir tablets; and oncology BCS class II drugs. The company also develops and commercializes single super specialty products comprising linezolid and formoterol. The company was incorporated in 2005 and is based in Hyderabad, India.
Key slides for Laurus Labs Ltd
Q2 24/25
Laurus Labs Ltd
Q2 24/25
Laurus Labs Ltd
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
LAURUSLABS
Country
🇮🇳 India